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ABSTRACT 
Background: There is paucity of local data on the profile of preterm very low birth weight (VLBW) 
infants who develop moderate to severe necrotising enterocolitis (NEC) and their outcomes.  
Methods: A retrospective folder review of VLBWs who developed Modified Bell’s stage II NEC or 
higher at Groote Schuur Hospital (GSH) nursery between January 2012 and December 2013 was 
performed. Outcomes were defined as requirement for surgery and mortality. 
Results: Forty seven infants were included (5% incidence). Gestational ages ranged from 25 to 36 
weeks, 53% were <1 000 g. The trend was for bigger infants to manifest disease earlier. The HIV 
exposure rate was 40% which was significantly higher than the background institutional exposure 
rate, but HIV exposure did not increase their mortality risk (p =0.82). Common findings at 
diagnosis included an elevated CRP >10 mg/L (60%) and subserosal gas radiologically (84%). Half 
the patients received mechanical ventilation, 38% required inotropes. The mortality rate was 
64%. Three of the five infants that received surgery survived. 
Conclusion: Despite a similar incidence to global counterparts, our VLBW infants have severe NEC 
disease often requiring advanced life support, with a high mortality rate. HIV exposure may 
increase the risk of NEC development. 
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INTRODUCTION 
 
Necrotising Enterocolitis (NEC) remains a common and serious gastrointestinal medical 
emergency occurring almost predominantly amongst the premature very low birth weight 
(VLBW) infants. The aetiology is multi-factorial and our understanding of the pathophysiology 
continues to evolve. It is described as there being an interplay between various factors such as 
immaturity of the gut, immaturity of the immune system and microbial dysbiosis affecting the 
premature gut which all invariably leads to mucosal injury 
The incidence worldwide is 2-7 %, but also varies within institutions (1, 2). NEC associated 
morbidity in survivors includes short-term surgical complications and long-term 
neurodevelopmental problems, with more severe neurodevelopmental impairment seen in 
those with disease that requires surgical intervention (3, 4). The mortality rate is 20-50 % in 
VLBWs, and even higher in the more premature and surgically treated infants but also varies 
between institutions (5, 6). 
 
The timing of development of NEC is inversely proportional to gestational age, usually occurring 
in the second or third week of life in premature VLBWs and earlier in term infants.  It classically 
affects the terminal ileum and the ascending colon (7). The severity varies as classified in the 
Modified Bell’s staging criteria (Appendix 1), with the more severe forms requiring intensive care 
support and surgical intervention. 
 
There has been a worldwide increase of in preterm deliveries and births over the past two 
decades with 11.1 % of infants now being born prematurely (<37 completed weeks of gestation) 
(8). A corresponding increase in survival rates of premature infants has also been witnessed with 
advances in neonatology and improvement in obstetric care (5). Locally a similar pattern has been 
exhibited at a central hospital in Johannesburg (9). However, there are still global disparities with 
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higher premature infant survival rates seen in high income countries compared to those in 
developing countries. This overall increase in premature infant survival rates has led to more 
infants living long enough to develop NEC and this plays a role in contributing to the neonatal 
and under 5 mortality rates. 
Deaths occurring during the neonatal period account for almost half the causes of mortality in 
the under 5 years (U5) populations with prematurity and its complications responsible for 35% 
of these, particularly in low income countries (10, 11). 
This makes NEC in premature infants a significant disease to study, particularly in the context of 
developing countries if we are to contribute in achieving the targets of the third United Nations 
Sustainable Development Goal. 
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LITERATURE REVIEW 
 
Although NEC is not a completely preventable disorder, it has well documented protective and 
risk factors. 
 
PROTECTIVE FACTORS 
• ANTENATAL STEROIDS 
The use of antenatal corticosteroids in expected preterm deliveries matures the intestinal 
system amongst other benefits and has been associated with a decrease incidence in NEC (12). 
An analysis of the 2011 WHO Multicountry Survey on Maternal and Newborn Health 
(WHOMCS) data obtained from 29 countries located in all the continents revealed that this 
intervention is underutilized in low and middle-income countries (13) 
 
• FEEDING 
A mother’s own, fortified breast milk is the ideal milk for growth and prevention of NEC amongst 
other benefits to a preterm infant (14). Human milk has several protective components including:   
Secretory IgA, which binds to the intestinal lumen and prevents bacteria translocation through 
the wall; Oligofructose, which enhances colonisation of the gut by bifidobacteria and also 
prevents colony by pathogenic bacteria. It also contains Platelet Activating Factor 
Acetylhydrolase (PAF-A), which metabolizes one of the proinflammatory markers platelet 
activating factor (PAF) noted in the pathogenesis of NEC (15). PAF-A activity is up to five times 
higher in the milk of mothers of preterm babies compared to those of term babies (16). 
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A mother’s own unpasteurized milk provides more biologically active molecules compared to 
pasteurized human milk and the quantity of raw maternal milk consumed compared to 
pasteurized human milk inversely correlates with NEC development (14, 17). 
 
It is acceptable practice to use pasteurized human donor milk as an alternative to augment the 
mother’s own, this has more favourable outcomes compared to formula. A 2014 Cochrane review 
by Quigley et al. of over 1000 infants compared the effect of formula vs. donated human milk on 
preterm or low birth weight infants. It showed that although formula was associated with more 
in-hospital growth, the risk of developing NEC is up to three times higher compared to those who 
receive donated human milk whether nutrient-fortified or not (18, 19) 
No decrease in the risk of NEC has not been demonstrated when comparing slower (15-
20ml/kg/day) versus faster (30-35ml/kg/day) rates of feeds advancement in VLBWs. Neither has 
a risk reduction been proven when feed introduction is delayed compared to commencing feeds 
early (20, 21) 
 
• PROBIOTICS 
Microbial dysbiosis is one of the currently recognized pathogenesis of NEC in premature infants. 
Probiotics, which also occur naturally in the breastmilk, can be administered as enteral 
supplementation to help promote good, symbiotic gut bacteria. The oral probiotics were shown 
to decrease the incidence, severity and mortality associated with NEC in a 2014 Cochrane review. 
A study conducted in South Africa by Van Niekerk et al. further demonstrated a decrease in NEC 
severity in HIV exposed preterm VLBW infants (22-24). 
However, further studies looking at the dosing and appropriate probiotic strains for routine 
administration are still required.  
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RISK FACTORS 
• MATERNAL PROFILE 
Maternal conditions that may lead to placental insufficiency and compromised blood flow to the 
intestines increase the risk of NEC development. Maternal methamphetamine use and 
hypertensive disorders in pregnancy are probably of greater interest in our South African 
population. Methamphetamine exposure, though only documented for term infants, increases 
the risk of developing NEC (25-27). In Western Cape, methamphetamine use is particularly 
endemic in the community (28). 
Pre-eclampsia and eclampsia are a common indication for premature delivery of infants globally 
and has also been shown to be a risk factor for NEC (29, 30). 
 
• PREMATURITY 
Prematurity alone is the most consistent independent risk factor for developing NEC largely due 
to an immature gut and immune system (31, 32). The immature gut has loose “tight junctions” 
which makes it easier for bacteria to invade it’s mucosa, has less secretory IgA and is colonized 
by fewer protective intestinal microflora, Bifidobacterium, amongst other factors (32, 33). 
 
• ANTIBIOTICS 
The use of prolonged broad-spectrum empiric antibiotics alters intestinal commensal flora thus 
increasing the risk of NEC (34-36). Prevention of acquired infections and judicious use of 
antibiotics is highly recommended. A decrease in incidence of NEC was seen at Groote Schuur 
Hospital with changes in these practices, development of standard operation protocols and hand 
hygiene vigilance (37) 
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• HIV EXPOSURE 
It is inconclusive whether HIV exposure contributes to increasing the risk of developing NEC, its 
severity or its outcomes. 
In 2005 Desfrere et al. from Italy suggested that there might be an increased association of NEC 
in HIV exposed premature infants (38). Locally, in 2010 Karpelowsky et al at Red Cross War 
Memorial Children’s Hospital, Cape Town, showed that premature HIV exposed infants requiring 
NEC surgery had a higher mortality rate compared to those who were HIV unexposed (39). 
However in 2012 Arnold’s group from Tygerberg Children’s Hospital, Stellenbosch, found that 
HIV exposure did not worsen the severity of disease or outcome of their infants with severe NEC  
and Angura et al in Johannesburg found that HIV exposure did not increase the risk of developing 
NEC (40, 41). 
 
There are also differences in the breast milk composition of HIV-Infected and HIV-Uninfected 
mothers of premature VLBW infants that have also been noted to exist and contributory in the 
development of NEC. One study showed the lower concentrations of human milk oligosaccharide 
disialyllacto-N-tetraose (DSLNT) in the breast milk of HIV infected mothers to be associated with 
an increased incidence of necrotising enterocolitis (42). 
 
Furthermore, a case study in Germany suggested a possible link between NEC and intravenous 
Zidovudine (AZT) exposure. This was observed in a term baby who developed NEC post AZT 
administration in the absence other identifiable risk factors, however this has not been described 
yet in premature infants (43). 
 
• RACE 
 
Black ethnicity increases the risk of NEC in some populations (44). 
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• BLOOD TRANSFUSION 
The phenomena of red blood cell “Transfusion Associated Necrotising Enterocolitis” (TANEC) is 
defined as NEC occurring within 48hrs of transfusion. A recent review of a multicentre 
observational cohort study in Georgia over a four year period between 2010 -2014 revealed that 
it is the severity of anaemia rather than the blood transfusion itself that is associated with 
increased NEC, transfusion merely was a surrogate marker (45). Preventative methods of 
decreasing anaemia requiring transfusion like delayed cord clamping  should be encouraged (46) 
 
DIAGNOSIS 
The modified Bell staging for NEC is a combined clinical and radiological classification of NEC 
widely used to classify severity (Appendix 1). The commonest clinical presentation is an ileus with 
gastric retention, abdominal distension, vomiting and perforation; contrary bloody stools are the 
least common (47). Systemic presentation includes apnoeas and hypotension. 
There are no specific diagnostic biochemical or septic markers, however several markers support 
the diagnosis. 
Hällström et al in a Finnish study described a laboratory parameter pattern that should increase 
a clinician’s index of suspicion for developing NEC and/or resultant intestinal perforation in a 
premature infant. In their prospective study of 140 premature infants, 19% developed NEC and 
they found that a metabolic acidosis that persists, declining platelets, persistent hyponatremia 
<130 mEq/l and rising blood glucose levels on several successive days might indicate a developing 
NEC. Furthermore a leukocyte count of >30 x 10(9)/L, a pH <7.25, and a blood glucose increase 
by 1.5 mmol/L or more within 24 hours predict NEC with intestinal perforation (48). 
Kenton et al. further supports that severe thrombocytopenia (<100 000/mm3) in early disease 
stages suggests significant bowel necrosis and worsening illness, it is also likely associated with 
an increase in mortality (49). In another group of neonates early neutropenia seen in small for 
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gestational age infants compared to appropriately grown ones is associated with poor prognosis 
in NEC (50). 
An elevated C-reactive protein (CRP) is usually present in moderate and severe NEC. A persistence 
in elevation of serial CRPs can be associated with complications of NEC (51). 
 
Primary invasion of the intestine by pathogenic bacteria has also been reported, blood cultures 
are positive in 20-30% of cases of NEC. Common isolates include Enterobacteria (Escherichia coli, 
Klebsiella pneumoniae), Clostridium spp. enteric pathogens (salmonellae, Coxsackie B2 virus, 
coronavirus, rotavirus), and occasional pathogens Bacteroides fragilis (52, 53) 
 
Abdominal radiography is the choice of investigation. Classical radiological findings range from 
abnormal gas pattern as seen in ileus in early NEC, progressing to the pathognomonic 
pneumatosis intestinalis, portal venous gas (PVG) and in severe cases pneumoperitoneum. 
Sentinel loops (a fixed loop of intestines) suggests necrosis and/or perforation. Traditionally PVG 
was considered a poor prognosticator and indication for surgery, however a review of 194 
neonates diagnosed with NEC done by Sharma et al at a unit in Florida between 1991-2003 did 
not support this, as there was no difference in the rate of survival in those with and without PVG 
(54). Radiological presentation appears to vary with gestational age - intramural gas and PVG are 
seen more commonly in those with older term gestational ages compared to those of younger 
premature gestational age (47) 
 
MANAGEMENT 
The management depends on the severity of disease manifestation - this includes bowel rest with 
parenteral nutrition, empiric treatment of possible underlying infection and surgery where 
indicated. Intensive care support and longer nursery admission is often required which has cost 
implications in our resource limited settings. 
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The absolute indication for surgical intervention is disease leading to bowel perforation. 
Appropriate timing of surgery requires input from paediatric surgery taking into consideration 
the clinical stability and biochemical changes of the patient (55).  Viable bowel preservation is 
the goal; laparotomy and percutaneous drainage may be of similar efficacy in initial management 
of perforations in extremely low birth weight infants (56, 57). Late post-surgery complications 
include formation of stricture, short bowel syndrome and much rarer enteroceles, intra-
abdominal abscesses. 
There is a paucity of data on the profile of infants who develop NEC and their outcome in SA, this 
study will look at this at a tertiary institute in Western Cape. 
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ABSTRACT 
 
Background: There is paucity of local data on the profile of preterm very low birth weight 
(VLBW) infants who develop moderate to severe necrotising enterocolitis (NEC) and their 
outcomes.  
 
Methods: A retrospective folder review of VLBWs who developed Modified Bell’s stage II NEC 
or higher at Groote Schuur Hospital (GSH) nursery between January 2012 and December 2013 
was performed. Outcomes were defined as requirement for surgery and mortality. 
Results: Forty seven infants were included (5% incidence). Gestational ages ranged from 25 to 36 
weeks, 53% were <1 000 g. The trend was for bigger infants to manifest disease earlier. The HIV 
exposure rate was 40% which was significantly higher than the background institutional exposure 
rate, but HIV exposure did not increase their mortality risk (p =0.82). Common findings at 
diagnosis included an elevated CRP >10 mg/L (60%) and subserosal gas radiologically (84%). 
Half the patients received mechanical ventilation, 38% required inotropes. The mortality rate was 
64%. Three of the five infants that received surgery survived. 
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Conclusion: Despite a similar incidence to global counterparts, our VLBW infants have severe 
NEC disease often requiring advanced life support, with a high mortality rate. HIV exposure may 
increase the risk of NEC development. 
 
 
INTRODUCTION 
 
NEC remains a common and serious gastrointestinal medical emergency occurring predominantly 
amongst preterm VLBW infants. It remains a noteworthy condition in the era of increased preterm 
deliveries and significant advances in neonatology and obstetric care leading to increased survival 
rates of preterm infants(8). It further contributes to the under 5 (U5) year mortality rates, where 
half the deaths occur in the neonatal period with complications of prematurity accounting for 35% 
of these, particularly in low income countries like South Africa(SA)(10). 
 
The incidence is reported to be 2-7% globally with institutional variation in incidence and stage of 
NEC studied(1, 2). The timing of development of NEC is inversely proportional to gestational age, 
typically occurring in the second or third week of life in preterm VLBW neonates and classically 
affecting the terminal ileum and the ascending colon. The aetiology is multi-factorial and our 
understanding of the pathophysiology continues to evolve. It is described as there being an 
interplay between various factors such as immaturity of the gut, immaturity of the immune system 
and microbial dysbiosis affecting the premature gut which leads to mucosal injury. Other 
associated risk factors include inadequate antenatal steroid use in preterm deliveries, feeding 
practices particularly infant formula feeding, race, severe anemia and HIV exposure. 
 
Pathogenic bacteria may lead to NEC by primary invasion of the intestines (53). 
Morbidity associated with survival of NEC includes short-term surgical complications e.g. short 
bowel syndrome and long-term neurodevelopmental impairment more profound than that 
secondary to prematurity alone(3).  Furthermore, more severe neurodevelopmental impairment is 
seen in those VLBW infants with NEC who require surgical intervention(4).The mortality rates in 
different institutions vary between 20-50%, however the consistent trend is a higher mortality in 
the very preterm and in surgically treated infants(5, 6). There is a paucity of data on the profile of 
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VLBW infants who develop this significant condition and their outcome in SA and other middle- 
or low-income countries. The objective of this study was therefore to describe the epidemiology, 
clinical features, relevant special investigations and outcomes of a cohort of VLBW infants in 
Cape Town, South Africa. 
METHODS 
The study was conducted at Groote Schuur Hospital (GSH), a tertiary neonatal unit in Cape Town, 
South Africa. At the time of the study, GSH neonatal unit admitted approximately 3 200 of 40 000 
newborns from the West Metro region of Cape Town yearly, with over 500 of these being VLBW. 
A retrospective folder review of infants who developed NEC at GSH from January 2012 up until 
December 2013 was performed. These infants were identified using the Vermont Oxford Network 
(VON) database of VLBW infants, a global database consisting of over 1000 neonatal intensive 
care units, of which GSH is one of the largest contributors. All VLBW infants who are admitted 
at GSH are entered into the VON database.  
Inclusion criteria were all neonates weighing ≤1 500 g who developed NEC Bell stage II or higher 
at GSH. (Table 1). Infants excluded were those referred to the unit already with a diagnosis of 
NEC, infants with primary gastrointestinal abnormalities and infants whose records could not be 
located.  
The data obtained from individual patient folders were entered onto a Microsoft Excel spreadsheet. 
Patient demographics included gestational age, birth weight, race, day of NEC occurrence, risk 
factors - such as type of infant feed and HIV exposure amongst others, diagnostic investigations 
and management. All abdominal radiographs were reviewed by the principal investigator and a 
neonatologist. 
All data were analysed descriptively which included means and standard deviations for normally 
distributed data and medians and inter-quartile ranges for non-normally distributed continuous 
data. Relative risks with 95% confidence intervals and p values were used to compare outcomes 
between deaths and survivors. Bivariate analysis was used to compare differences in the death and 
survivor groups; Chi-squared tests for categorical data, T-tests for normally distributed numeric 
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data and the Mann Whitney U test for non-parametric numeric data. The Shapiro Wilk testing was 
used to assess if data was normally distributed. Statistical significance was set at p<0.05 
Approval by the Human Research Ethics Committee of the University of Cape Town Faculty of 
Health Sciences was obtained (HREC Ref: 776/2016) 
RESULTS 
Sixty-three of 1 032 (6%) VLBW infants admitted over the two-year period were identified as 
having a diagnosis of NEC from the VON database. 16 were excluded from the study: 5 had 
developed NEC elsewhere, 1 patient had a duodenal atresia repair prior to developing NEC and 10 
folders could not be located. The study sample was 47 infants (5% incidence). 
 
Maternal profile 
Five mothers did not receive any antenatal care and one of them delivered an infant with congenital 
syphilis. 36 mothers (77%) received at least one dose of antenatal steroids (ANS). This is higher 
than the background rate of 58% steroid exposure of all VLBWs over the same time period 
(p=0.01). Amongst those that developed NEC, the use of ANS did not protect against the need for 
surgery (p=0.69). 
Of the 21 (45%) mothers who had a hypertensive disorder, 20 had early onset pre-eclamptic 
toxemia (EOPET) and one had pre-existing chronic hypertension. The incidence of pre-eclamptic 
toxemia (PET) was similar to the background rate of 47% for all VLBW births at GSH and was 
the commonest indication for early delivery. 
19 mothers (40%) were HIV-positive. 11 of these mothers were on at least 3 months of 
antiretroviral therapy (ART) as per the 2010 national Prevention of Mother to Child Transmission 
(PMTCT) guidelines applicable at the time. The other 8 mothers had either less than 3 months or 
no ART. 
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Table 1.  Summary of NEC Modified Bell Staging 
STAG
E 
CLASSIFICATIO
N OF NEC 
SYSTEMIC SIGNS ABDOMINA
L SIGNS 
RADIOGRAPHI
C SIGNS 
1A Suspected NEC Clinically ill Absent bowel 
sounds, 
abdominal 
distension, 
Increased 
nasogastric 
aspirates, 
vomiting 
Normal/mild 
intestinal dilatation, 
mild ileus 
1B Suspected NEC Grossly bloody 
stools 
2A Definite,  mildly ill Mild-moderate 
illness 
Absent bowel 
sounds 
Intestinal dilatation, 
ileus, pneumatosis 
intestinalis, portal 
venous gas 
2B Definite,  moderately 
ill 
 As above + Ascites 
3A Advanced, severely 
ill, intact bowel 
Severely ill (apnoea, 
bradycardia, 
hypotension.  
Mixed 
metabolic/respirator
y acidosis, DIC 
Marked 
tenderness, 
marked 
distension, 
peritonitis 
3B Advanced, severely 
ill, perforated bowel 
All above + 
pneumoperitoneum 
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Infants 
The infants’ demographics showed that 57% (n= 27) were black Africans and 43% (n= 20) were 
of mixed ancestry. Their gestational ages ranged from 25 weeks to 36 weeks. 25 (53%) were below 
1000 g 
Most (77%) of these infants developed NEC in the first 3 weeks of life, with 17 (36%) occurring 
in the first 10 days (Figure 1). The trend was for the larger infants to develop NEC earlier than the 
smaller ones 
Feeding: 
Sixty percent of the infants received exclusive breastmilk (either mother’s own or pasteurized 
donated milk). (Figure 2.)  All mothers who were HIV-positive pasteurized their milk. 5 of the 19 
(26%)  HIV exposed infants also received some formula feed(s). 
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Figure 1. Graph demonstrating day of NEC occurence according to 
birth weight 
W
EIGHT (g)
DAY OF NEC OCCURENCE
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Four babies (8%) developed NEC within 48 hours of receiving a red blood cell transfusion i.e. 
transfusion associated NEC (TANEC). Their haemoglobin ranged between 6.8- 9.9 g/dL on the 
day of transfusion.  
Laboratory and radiological Diagnosis: 
At diagnosis and initial work-up, an elevated CRP >10 mg/dL was the most commonly found 
laboratory marker in this group (60% of infants). A quarter of the infants were thrombocytopenic 
(Table 2) There were 14 (30%) infants with a positive blood culture growth: Gram-negative 
organisms especially ESBL Klebsiella (n= 4) and E.Coli (n= 3) were the most commonly found.
28
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Figure 2.  Graph showing milk feeds distribution in the 
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Table 2. Laboratory markers at the time of diagnosis 
Radiologically, the commonest finding at diagnosis was the ‘soap bubble’ appearance which may 
indicate subserosal gas (84% of all abdominal radiographs). Linear pneumatosis intestinalis 
(submucosal gas) was seen in 45% of the images, 29% showed portal venous gas and 2% had 
pneumoperitoneum.  
Management 
Fifty-three percent (n= 25) of the babies required mechanical ventilation and 38% (n=13) 
additional inotropic support. TPN was commenced in 23 babies, of these who received TPN 60% 
received more than 7 days of TPN. Blood products including platelets, fresh frozen plasma were 
given in 38%. 
Outcome 
There was a high mortality rate of 64% (n= 30) (Figure 3).  Most deaths (60%) occurred in the 
infants born ≤ 1 000 g. There was a trend towards statistical significant in the difference in 
mortality between this weight category and the 1 001-1 500 g infants (p= 0.05). Twenty (42%) 
Range Mean Comments 
CRP (mg/L) 1 - 146 30 60% had a CRP <10 
WCC (x10^9/L) 0.95 - 27 10 17% neutropenic 
Platelets (x10^9/L) 19 - 743 360 25% 
thrombocytopenic 
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infants died within 48hrs of presentation. Babies with HIV exposure did not have a significantly 
increased risk of death (p=0.82) 
Laparotomies were performed on five babies at Red Cross War Memorial Childrens’ Hospital. 
 
Figure 3. Illustration showing NEC patient outcomes 
 
 
 
DISCUSSION 
 
Although our NEC incidence during this study fell within the 2-7% expected for VLBW infants, 
we had a higher (64%) mortality rate than is usually quoted, with most of the deaths, 20 of 30 
(60%), occurring in the <1000g infants. Despite intensive care, two thirds of those infants that died 
did so within 48 hours with many of them being too unstable to transfer for surgery. Only 5 infants 
underwent a laparotomy. 
NEC
n=47
No Surgery
n=42
Alive
14
Demised
28
Surgery
n=5
Alive
3 
Demised
2
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In our cohort there were 19 (40%) HIV-exposed infants, a significantly higher rate than that 
reported overall for HIV-exposure rate of 20% in VLBWs during that time period (p=0.001)(58). 
This may support a hypothesis that HIV exposure is associated with an increased risk of developing 
NEC.  
The literature is divided about whether HIV-exposure contributes to the risk of developing NEC, 
its severity or its outcomes. In 2005 Desfrere et al., in Italy suggested that there might be an 
increased association of NEC in HIV exposed preterm infants(38). A local study in 2010, from 
Red Cross War Memorial Children’s Hospital showed that preterm HIV-exposed infants requiring 
NEC surgery had a higher mortality rate compared to those who were HIV-unexposed (39).  
Lower concentrations of human milk oligosaccharide disialyllacto-N-tetraose (DSLNT) in the 
breast milk of HIV infected mothers has also been described to be associated with an increased 
incidence of necrotising enterocolitis(42). A German case study suggested a possible association 
of intravenous Zidovudine used as prophylaxis in PMTCT with NEC development, this was seen 
in a term infant who developed NEC shortly after exposure with no other risk factors (43), this 
however has not yet  been described in preterm infants. Two local studies from Cape Town and 
Johannesburg in 2012 and 2014 respectively, reported that HIV-exposure did not increase the risk 
of developing NEC, and neither did it worsen the severity or outcome of those with stage III NEC 
(40, 41). 
The maternal condition of PET is known globally as the commonest indication for preterm 
delivery, and is also postulated as a risk factor for NEC(30). At GSH however, almost half the 
mothers of VLBW infants are delivered due to EOPET by emergency caesarean section and there 
is no difference in the incidence of PET in the mothers of the babies who develop NEC.  
A 2017 Cochrane review stated that the use of antenatal steroids (ANS) in anticipated preterm 
births has been shown to reduce the risk of NEC  (RR 0.50, 95% CI 0.32-0.78) (12). In this study, 
77% of mothers received antenatal steroids which is close to the 80% seen in high income 
countries(HIC) (13). This was significantly higher than the background rate of maternal steroid 
administration (58%) in our unit. This could possibly be explained by the hypothesis that infants 
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who were not steroid exposed would have a higher chance of dying in the first few days of life due 
to respiratory distress syndrome and therefore never develop NEC 
Infant factors 
NEC timing 
The timing of development of NEC is inversely proportional to gestational age. Our study showed 
similar findings and the trend was for the larger infants to develop NEC earlier than the smaller 
ones. Over one third of the infants developed NEC within the first 10 days of life, this was in 
keeping with global patterns(7) 
Feeds 
A 2014 Cochrane review by Quigley et al., of over 1 000 infants compared the effect of formula 
versus donated human milk on preterm or low birth weight infants. It showed that although formula 
was associated with more in-hospital growth, the risk of developing NEC is up to three times 
higher compared to those who receive donated human milk (18). Approximately 40% of the infants 
received some formula feed(s) at some point during their hospitalization due to either milk 
unavailability from their mother or their ineligibility for donor breastmilk as per our unit’s 
qualifying criterion (i.e. >1 200 g at the time). Of note, a mother’s own unpasteurized milk provides 
more biologically active molecules compared to pasteurized human milk and the quantity of raw 
maternal milk consumed compared to pasteurized human milk inversely correlates with NEC 
development (16). 
TANEC 
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Four infants who required a standard blood transfusion developed NEC within 48hrs post 
transfusion. These had been transfused according to the unit’s restrictive blood transfusion policy 
which allows a lower hemoglobin threshold for transfusing preterm infants (37).   
This phenomenon of red blood cell TANEC has been defined as NEC occurring within 48 hours 
of transfusion. This association has been described as early as 1987(59), the main hypothesis was 
possibly low velocity flow of the mesenteric blood in the post-transfusion state predisposing to 
intestinal injury.  
 
These theories of TANEC have been dispelled in more recent studies. Of note is the multicenter 
observational cohort study in Atlanta, Georgia conducted between 2010 -2014 which revealed that 
it is the severity of anemia rather than the blood transfusion itself that is associated with increased 
NEC. Transfusion was deemed merely a surrogate marker of severity(45) 
 
Diagnosis 
 
The diagnosis is made using the Modified Bell’s staging criteria for NEC (clinical and 
radiological), there are no specific diagnostic biochemical or septic markers, however several 
markers support the diagnosis such as increased inflammatory markers and abnormal white cell 
and platelets blood counts. A Finnish prospective study of 140 preterm neonates where 19% 
developed NEC found that a leukocyte count of >30 x 10(9)/L, a pH <7.25, and a blood glucose 
increase by 1.5 mmol/L or more within 24 hours predict NEC with intestinal perforation (23)  Most 
of the patients in our study had a white cell and platelet count in the normal ranges at diagnosis 
with only 25% classified as thrombocytopenic. However, thrombocytopenia may only develop 
later in the course of the disease. 
 
An elevated C-reactive protein (CRP) is usually present in moderate and severe NEC. A 
persistence in elevation of serial CRPs can be associated with complications of NEC (51). A raised 
CRP>10 mg/L was present in 60% of our infants at diagnosis. Due to peaking of CRP levels at 36-
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48hrs after the start of inflammation it is likely that some of the infants may have only had a raised 
CRP the day after diagnosis. 
Primary invasion of the intestine by pathogenic bacteria has also been reported and blood cultures 
are positive in 20-30% of cases of NEC. Common isolates include Enterobacteriaceae 
(Escherichia coli, Klebsiella pneumoniae), Clostridium spp. and enteric pathogens (salmonellae, 
coxsackie B2 virus, coronavirus, rotavirus)(53). Similar rate of positive blood cultures was 
observed in our study (30%), however resistant strains of Gram-negative organisms were the most 
cultured organisms - especially ESBL Klebsiella (n= 4) and E.Coli (n= 3)   
Management and outcomes 
The management depends on the severity of disease manifestation, it includes bowel rest with 
parenteral nutrition, empiric treatment of possible underlying infection, ventilatory and circulatory 
support, and surgery where indicated. The absolute indication for surgical intervention is disease 
leading to bowel perforation.  
Upon establishing a diagnosis of NEC, all the infants in this study were transferred to the NICU, 
they were initiated on empiric second line antibiotics as per the unit’s microbiological profiling at 
the time. Only half the patients received TPN, mostly because of the many deaths soon after 
diagnosis.  TPN was required for 5-14 days. Fifty-three percent required invasive ventilation 
within 24hours of diagnosis. 13 infants required inotropic support. The magnitude of ventilatory 
and inotropic support required, illustrates the severity of illness which also has both resource and 
cost implications. 
The mortality rate is 20-50% in different institutions, whilst our rate in this study was particularly 
high at 64%, with the majority being amongst the <1000g infants. Only 5 infants received 
laparotomies of which three survived to discharge. As surgery takes place off-site at Red Cross 
War Memorial Children’s hospital many babies were too unstable to transfer. There was 
incomplete data regarding short-term neurodevelopmental follow-up. 
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The major limitations to this study were the retrospective nature and the small sample size. The 10 
missing folders not analysed further undermined the power of the study. The setting was a tertiary 
unit with a higher than usual maternal cohort having a diagnosis of gestational hypertension, 
therefore we cannot generalize findings to other less specialized hospitals. 
Future study considerations should include a bigger size sample, the role that introduction of 
probiotics has played and exploring further the role of HIV/ ARV exposure in the development of 
NEC in the context of the current PMTCT Option B+ regimen which uses more ART compared 
to the previous regimen. 
CONCLUSIONS 
In this study of 47 VLBW infants with NEC, there was a high mortality (64%) with death within 
48hrs of diagnosis being common, particularly in those < 1 000 g (20 of 30 infants). A raised CRP 
>10 mg/L was the most reliable biochemical marker at presentation on the day of NEC occurrence
and the most commonly seen radiological sign was sub-serosal gas.  One third of the VLBW
infants developed NEC within the first 10 days of life. Whilst HIV-exposure did not increase the
risk of mortality, there is possibly an associated increased risk of NEC development with HIV
exposure and this finding warrants further investigation.
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Table 1.  Summary of NEC Modified Bell Staging 
STAG
E 
CLASSIFICATIO
N OF NEC 
SYSTEMIC SIGNS ABDOMINA
L SIGNS 
RADIOGRAPHI
C SIGNS 
1A Suspected NEC Clinically ill Absent bowel 
sounds, 
abdominal 
distension, 
Increased 
nasogastric 
aspirates, 
vomiting 
Normal/mild 
intestinal dilatation, 
mild ileus 
1B Suspected NEC Grossly bloody 
stools 
2A Definite,  mildly ill Mild-moderate 
illness 
Absent bowel 
sounds 
Intestinal dilatation, 
ileus, pneumatosis 
intestinalis, portal 
venous gas 
2B Definite,  moderately 
ill 
 As above + Ascites 
3A Advanced, severely 
ill, intact bowel 
Severely ill (apnoea, 
bradycardia, 
hypotension.  
Mixed 
metabolic/respirator
y acidosis, DIC 
Marked 
tenderness, 
marked 
distension, 
peritonitis 
3B Advanced, severely 
ill, perforated bowel 
All above + 
pneumoperitoneum 
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Figure 1. Graph demonstrating day of NEC occurence according to 
birth weight 
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Figure 2.  Graph showing milk feeds distribution in the cohort
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Table 2. Laboratory markers at the time of diagnosis 
Range Mean Comments 
CRP (mg/L) 1 - 146 30 60% had a CRP <10 
WCC (x10^9/L) 0.95 - 27 10 17% neutropenic 
Platelets (x10^9/L) 19 - 743 360 25% 
thrombocytopenic 
Figure 3. Illustration showing NEC patient outcomes 
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